Trending Now
BUSINESS
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...
Cellectis a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has...
MEDICAL DEVICES
MANUFACTURING
Thermo Fisher Scientific Acquires MTI-GlobalStem
Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a purchase agreement to acquire MTI-GlobalStem, a privately-held company that...
DON'T MISS
JOURNAL SPOTLIGHT
Stem cell biologist at Harvard retracts diabetes breakthrough manuscript published in...
A diabetes breakthrough manuscript published by Douglas A. Melton, PhD, Co-Director of Harvard Stem Cell Institute (Ref: Cell 153, 747–758; May 9, 2013)
In this article,...
EVEN MORE NEWS
